Recent Advances in Cancer Immunotherapy Delivery Modalities

Muthukutty, Palaniyandi; Woo, Hyun Young; Ragothaman, Murali; Yoo, So Young

doi:10.3390/pharmaceutics15020504

Open AccessReview

Recent Advances in Cancer Immunotherapy Delivery Modalities

by

Palaniyandi Muthukutty

^1,†

,

Hyun Young Woo

^2,†,

Murali Ragothaman

¹ and

So Young Yoo

^1,*

¹

BIO-IT Foundry Technology Institute, Pusan National University, Busan 46241, Republic of Korea

²

Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea

^*

Author to whom correspondence should be addressed.

^†

These authors contributed equally to this work.

Pharmaceutics 2023, 15(2), 504; https://doi.org/10.3390/pharmaceutics15020504

Submission received: 7 January 2023 / Revised: 25 January 2023 / Accepted: 31 January 2023 / Published: 2 February 2023

(This article belongs to the Special Issue Drug Repurposing and Delivery Systems for Immunotherapy)

Download

Browse Figures

Versions Notes

Abstract

Immunotherapy is crucial in fighting cancer and achieving successful remission. Many novel strategies have recently developed, but there are still some obstacles to overcome before we can effectively attack the cancer cells and decimate the cancer environment by inducing a cascade of immune responses. To successfully demonstrate antitumor activity, immune cells must be delivered to cancer cells and exposed to the immune system. Such cutting-edge technology necessitates meticulously designed delivery methods with no loss or superior homing onto cancer environments, as well as high therapeutic efficacy and fewer adverse events. In this paper, we discuss recent advances in cancer immunotherapy delivery techniques, as well as their future prospects.

Keywords: drug delivery; cancer immunotherapy; CAR-T cells; nanoparticles

Share and Cite

MDPI and ACS Style

Muthukutty, P.; Woo, H.Y.; Ragothaman, M.; Yoo, S.Y. Recent Advances in Cancer Immunotherapy Delivery Modalities. Pharmaceutics 2023, 15, 504. https://doi.org/10.3390/pharmaceutics15020504

AMA Style

Muthukutty P, Woo HY, Ragothaman M, Yoo SY. Recent Advances in Cancer Immunotherapy Delivery Modalities. Pharmaceutics. 2023; 15(2):504. https://doi.org/10.3390/pharmaceutics15020504

Chicago/Turabian Style

Muthukutty, Palaniyandi, Hyun Young Woo, Murali Ragothaman, and So Young Yoo. 2023. "Recent Advances in Cancer Immunotherapy Delivery Modalities" Pharmaceutics 15, no. 2: 504. https://doi.org/10.3390/pharmaceutics15020504

APA Style

Muthukutty, P., Woo, H. Y., Ragothaman, M., & Yoo, S. Y. (2023). Recent Advances in Cancer Immunotherapy Delivery Modalities. Pharmaceutics, 15(2), 504. https://doi.org/10.3390/pharmaceutics15020504

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Recent Advances in Cancer Immunotherapy Delivery Modalities

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI